Bioventus Inc. (BVS) News
Track canonical SquawkNews coverage tagged to BVS, Bioventus Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 9 indexed stories across 8 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
Bravura Solutions appoints Ian Whiting as non-executive director
Bravura Solutions Limited says it has appointed Mr. Ian Whiting as a non-executive director with immediate effect.
EQUITY | Sep 08, 2026, 06:30 AM UTC
L
Bravura Solutions director shareholding update via restricted share award
Bravura Solutions Limited confirmed a restricted share award under its FY26 Incentive Plan as part of a director/PDMR shareholding update.
EQUITY | Sep 02, 2026, 04:00 PM UTC
L
Bravura Solutions issues correction to annual report
Bravura Solutions has filed a correction to its annual report.
EQUITY | Aug 28, 2026, 07:00 AM UTC
H
Deal Dispatch: Bending Spoons Acquires Airtable, Bain Capital Buys Gong Cha Global, Salad and Go Bankruptcy
New On The Block Digital Brands Group, Inc. (NASDAQ: DBGI ), an apparel and e-commerce company, hired Roth Capital Partners as its financial adviser to assist in a strategic review, including a sale or merger. AquaBounty
EARNINGS | Aug 07, 2026, 05:12 PM UTC
L
Bioventus Affirms FY2026 Adj EPS Guidance of $0.75-$0.79 vs $0.78 Est; Affirms FY2026 Sales Guidance of $600.000M-$610.000M vs $605.756M Est
Bioventus (NASDAQ: BVS ) affirms FY2026 Adj EPS guidance from $0.75-$0.79 to $0.75-$0.79 vs $0.78 analyst estimate. Affirms FY2026 sales outlook from $600.000 million-$610.000 million to $600.000 million-$610.000 million
EARNINGS | Aug 05, 2026, 11:31 AM UTC
L
BVS - Bioventus Reports Second Quarter Financial Results
BVS - Bioventus Reports Second Quarter Financial Results
EARNINGS | Aug 05, 2026, 11:30 AM UTC
L
BVS - Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
BVS - Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026
EARNINGS | Jul 29, 2026, 12:31 PM UTC
L
Did Bioventus Inc. Insiders Breach their Fiduciary Duties to Shareholders?
Did Bioventus Inc. Insiders Breach their Fiduciary Duti
EQUITY | Jul 03, 2026, 04:24 PM UTC
L
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Seer (NASDAQ: SEER ) stock moved upwards by 33.3% to $2.16 during Thursday's after-market session. The market value of their outstanding shares is at $89.6 million. Universe Pharmaceuticals (NASDAQ: UPC ) stock m
EQUITY | Jul 02, 2026, 09:05 PM UTC